Literature DB >> 12658773

The effect and mechanism of forsinopril on ventricular hypertrophy of SHR and left ventricular pressure overloading rat.

Kai Huang1, Guizhu Dai.   

Abstract

The effects and mechanism of long-term angiotensin converting enzyme inhibitor (ACEI) Forsinopril on left ventricular hypertrophy of spontaneous hypertension rat (SHR) and left ventricular pressure overloading rat were studied. The left ventricular index (left ventricle weight/body weight) was used to evaluate left ventricular hypertrophy and the in situ hybridization to investigate the TGF-beta 1 gene expression in left ventricle. The results showed that Forsinopril significantly decreased the left ventricular index of both SHR and left ventricle pressure overloading rat. Forsinopril reduced the integral photic density of TGF-beta 1 gene statement from 2.836 +/- 0.314 to 1.91 +/- 0.217 (P < 0.01, n = 8) of SHR rat and from 3.071 +/- 0.456 to 2.376 +/- 0.379 (P < 0.01, n = 8) of left ventricular pressure overloading rat respectively. It was concluded that Forsinopril could prevent the occurrence of left ventricular hypertrophy and reduce the TGF-beta 1 gene expression in left ventricle of both SHR and left ventricular pressure overloading rat significantly.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12658773     DOI: 10.1007/BF02904778

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  19 in total

1.  Differential regulation of skeletal alpha-actin transcription in cardiac muscle by two fibroblast growth factors.

Authors:  T G Parker; K L Chow; R J Schwartz; M D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat.

Authors:  E P Kromer; G A Riegger
Journal:  Am J Cardiol       Date:  1988-07-01       Impact factor: 2.778

3.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta.

Authors:  P Rossi; G Karsenty; A B Roberts; N S Roche; M B Sporn; B de Crombrugghe
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

4.  Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes.

Authors:  T G Parker; S E Packer; M D Schneider
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

5.  Angiotensin I converting enzyme gene cosegregates with blood pressure and heart weight in F2 progeny derived from spontaneously hypertensive and normotensive Wistar-Kyoto rats.

Authors:  L Zhang; K M Summers; M J West
Journal:  Clin Exp Hypertens       Date:  1996-08       Impact factor: 1.749

6.  Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.

Authors:  S Kim; K Ohta; A Hamaguchi; T Omura; T Yukimura; K Miura; Y Inada; Y Ishimura; F Chatani; H Iwao
Journal:  J Pharmacol Exp Ther       Date:  1995-04       Impact factor: 4.030

7.  Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts.

Authors:  N N Kim; F J Villarreal; M P Printz; A A Lee; W H Dillmann
Journal:  Am J Physiol       Date:  1995-09

8.  Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy.

Authors:  T Yamazaki; I Komuro; S Kudoh; Y Zou; I Shiojima; T Mizuno; H Takano; Y Hiroi; K Ueki; K Tobe
Journal:  Circ Res       Date:  1995-08       Impact factor: 17.367

9.  Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure.

Authors:  T W Kurtz; L Simonet; P M Kabra; S Wolfe; L Chan; B L Hjelle
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

10.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

Authors:  D R Edwards; G Murphy; J J Reynolds; S E Whitham; A J Docherty; P Angel; J K Heath
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.